Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Sotalol Drug Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Tablet
  • 1.3.3 Oral solution
  • 1.3.4 Injection
• 1.4 Market Segment by Application
  • 1.4.1 Global Sotalol Drug Market Share by Application (2019-2025)
  • 1.4.2 Ventricular arrhythmias
  • 1.4.3 Supraventricular arrhythmias
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Sotalol Drug Market Size
  • 2.1.1 Global Sotalol Drug Revenue 2014-2025
  • 2.1.2 Global Sotalol Drug Sales 2014-2025
• 2.2 Sotalol Drug Growth Rate by Regions
  • 2.2.1 Global Sotalol Drug Sales by Regions 2014-2019
  • 2.2.2 Global Sotalol Drug Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Sotalol Drug Sales by Manufacturers
  • 3.1.1 Sotalol Drug Sales by Manufacturers 2014-2019
  • 3.1.2 Sotalol Drug Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Sotalol Drug Revenue by Manufacturers (2014-2019)
  • 3.2.2 Sotalol Drug Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Sotalol Drug Market Concentration Ratio (CR5 and HHI)
• 3.3 Sotalol Drug Price by Manufacturers
• 3.4 Key Manufacturers Sotalol Drug Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Sotalol Drug Market
• 3.6 Key Manufacturers Sotalol Drug Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Tablet Sales and Revenue (2014-2019)
  • 4.1.2 Oral solution Sales and Revenue (2014-2019)
  • 4.1.3 Injection Sales and Revenue (2014-2019)
• 4.2 Global Sotalol Drug Sales Market Share by Type
• 4.3 Global Sotalol Drug Revenue Market Share by Type
• 4.4 Sotalol Drug Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Sotalol Drug Sales by Application

6 United States

• 6.1 United States Sotalol Drug Breakdown Data by Company
• 6.2 United States Sotalol Drug Breakdown Data by Type
• 6.3 United States Sotalol Drug Breakdown Data by Application

7 European Union

• 7.1 European Union Sotalol Drug Breakdown Data by Company
• 7.2 European Union Sotalol Drug Breakdown Data by Type
• 7.3 European Union Sotalol Drug Breakdown Data by Application

8 China

• 8.1 China Sotalol Drug Breakdown Data by Company
• 8.2 China Sotalol Drug Breakdown Data by Type
• 8.3 China Sotalol Drug Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Sotalol Drug Breakdown Data by Company
• 9.2 Rest of World Sotalol Drug Breakdown Data by Type
• 9.3 Rest of World Sotalol Drug Breakdown Data by Application
• 9.4 Rest of World Sotalol Drug Breakdown Data by Countries
  • 9.4.1 Rest of World Sotalol Drug Sales by Countries
  • 9.4.2 Rest of World Sotalol Drug Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Bayer HealthCare
  • 10.1.1 Bayer HealthCare Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Sotalol Drug
  • 10.1.4 Sotalol Drug Product Introduction
  • 10.1.5 Bayer HealthCare Recent Development
• 10.2 Mylan
  • 10.2.1 Mylan Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Sotalol Drug
  • 10.2.4 Sotalol Drug Product Introduction
  • 10.2.5 Mylan Recent Development
• 10.3 Arbor Pharmaceuticals
  • 10.3.1 Arbor Pharmaceuticals Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Sotalol Drug
  • 10.3.4 Sotalol Drug Product Introduction
  • 10.3.5 Arbor Pharmaceuticals Recent Development
• 10.4 Upsher-Smith Laboratories
  • 10.4.1 Upsher-Smith Laboratories Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Sotalol Drug
  • 10.4.4 Sotalol Drug Product Introduction
  • 10.4.5 Upsher-Smith Laboratories Recent Development
• 10.5 AltaThera Pharmaceuticals
  • 10.5.1 AltaThera Pharmaceuticals Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Sotalol Drug
  • 10.5.4 Sotalol Drug Product Introduction
  • 10.5.5 AltaThera Pharmaceuticals Recent Development
• 10.6 Teva
  • 10.6.1 Teva Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Sotalol Drug
  • 10.6.4 Sotalol Drug Product Introduction
  • 10.6.5 Teva Recent Development
• 10.7 Apotex
  • 10.7.1 Apotex Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Sotalol Drug
  • 10.7.4 Sotalol Drug Product Introduction
  • 10.7.5 Apotex Recent Development
• 10.8 Epic Pharma
  • 10.8.1 Epic Pharma Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Sotalol Drug
  • 10.8.4 Sotalol Drug Product Introduction
  • 10.8.5 Epic Pharma Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Sotalol Drug Sales Channels
  • 11.2.2 Sotalol Drug Distributors
• 11.3 Sotalol Drug Customers

12 Market Forecast

• 12.1 Global Sotalol Drug Sales and Revenue Forecast 2019-2025
• 12.2 Global Sotalol Drug Sales Forecast by Type
• 12.3 Global Sotalol Drug Sales Forecast by Application
• 12.4 Sotalol Drug Forecast by Regions
  • 12.4.1 Global Sotalol Drug Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Sotalol Drug Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Sotalol is a medication used to treat abnormal heart rhythms.
In 2019, the market size of Sotalol Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sotalol Drug.

This report studies the global market size of Sotalol Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Sotalol Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Bayer HealthCare
Mylan
Arbor Pharmaceuticals
Upsher-Smith Laboratories
AltaThera Pharmaceuticals
Teva
Apotex
Epic Pharma

Market Segment by Product Type
Tablet
Oral solution
Injection

Market Segment by Application
Ventricular arrhythmias
Supraventricular arrhythmias

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Sotalol Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Sotalol Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Sotalol Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025